Belite Bio- Adr logo

Belite Bio- Adr Share Price Today

(NASDAQ: BLTE)

Belite Bio- Adr share price is $60.36 & ₹5,249.45 as on 6 Mar 2025, 2.30 'hrs' IST

$60.36

0.56

(0.94%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Belite Bio- Adr share price in Dollar and Rupees. Guide to invest in Belite Bio- Adr stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Belite Bio- Adr, along with analyst recommendations, forecasts, and comprehensive financials.

Belite Bio- Adr share price movements

  • Today's Low: $59.30
    Today's High: $61.22

    Day's Volatility :3.14%

  • 52 Weeks Low: $31.01
    52 Weeks High: $86.53

    52 Weeks Volatility :64.17%

Belite Bio- Adr (BLTE) Returns

PeriodBelite Bio Inc - AdrSector (Health Care)Index (Russel 2000)
3 Months
-8.02%
2.1%
0.0%
6 Months
22.54%
-4.1%
0.0%
1 Year
28.6%
2.2%
0.0%
3 Years
308.19%
11.8%
-11.6%

Belite Bio- Adr (BLTE) Key Statistics

in dollars & INR

Previous Close
$59.8
Open
$59.3097
Today's High
$61.22
Today's Low
$59.3
Market Capitalization
$1.9B
Today's Volume
$12.5K
52 Week High
$86.53
52 Week Low
$31.005
Revenue TTM
$0.0
EBITDA
$-35.3M
Earnings Per Share (EPS)
$-1.15
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-40.04%

How to invest in Belite Bio- Adr Stock (BLTE) from India?

It is very easy for Indian residents to invest directly in Belite Bio- Adr from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Belite Bio- Adr stock in both Indian Rupees (INR) and US Dollars (USD). Search for Belite Bio- Adr or BLTE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Belite Bio- Adr or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Belite Bio- Adr shares which would translate to 0.014 fractional shares of Belite Bio- Adr as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Belite Bio- Adr, in just a few clicks!

Returns in Belite Bio- Adr (BLTE) for Indian investors in Rupees

The Belite Bio- Adr stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Belite Bio- Adr investment value today

Current value as on today

₹1,34,769

Returns

₹34,769

(+34.77%)

Returns from Belite Bio- Adr Stock

₹29,806 (+29.81%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Belite Bio- Adr (BLTE)

-50%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Belite Bio- Adr Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Belite Bio- Adr

  • Armistice Capital, LLC

    0.53%

  • State Street Corp

    0.06%

  • Bank of America Corp

    0.06%

  • JPMorgan Chase & Co

    0.05%

  • UBS Group AG

    0.04%

  • Morgan Stanley - Brokerage Accounts

    0.03%

Analyst Recommendation on Belite Bio- Adr

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Belite Bio- Adr(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Belite Bio- Adr Stock (BLTE)

What analysts predicted

Upside of 40.41%

Target:

$84.75

Current:

$60.36

Insights on Belite Bio- Adr Stock (Ticker Symbol: BLTE)

  • Price Movement

    In the last 7 days, BLTE stock has moved up by 7.7%
  • BLTE vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 34.5%

Belite Bio- Adr Technicals Summary

Sell

Neutral

Buy

Belite Bio- Adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Belite Bio- Adr (BLTE) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Belite Bio Inc - Adr logo
3.0%
22.54%
28.6%
308.19%
308.19%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Belite Bio Inc - Adr logo
NA
NA
NA
-1.18
-0.4
-0.26
NA
3.63
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Belite Bio Inc - Adr logo
Buy
$1.9B
308.19%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Belite Bio- Adr

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Organization
Belite Bio- Adr
Employees
20
CEO
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Industry
Healthcare

Management People of Belite Bio- Adr

NameTitle
Dr. Yu-Hsin Lin M.B.A., Ph.D.
Chairman of the Board of Directors & CEO
Mr. Hao-Yuan Chuang C.F.A., F.R.M., M.B.A.
CFO & Director
Dr. Nathan L. Mata Ph.D.
Chief Scientific Officer
Dr. Hendrik P.N. Scholl M.A., M.D., Ph.D.
Chief Medical Officer & Member of Ophthalmology Clinical Advisory Board

Important FAQs about investing in BLTE Stock from India :

What is Belite Bio- Adr share price today?

Belite Bio- Adr share price today stands at $60.36, Open: $59.31 ; Previous Close: $59.80 ; High: $61.22 ; Low: $59.30 ; 52 Week High: $86.53 ; 52 Week Low: $31.01.

The stock opens at $59.31, after a previous close of $59.80. The stock reached a daily high of $61.22 and a low of $59.30, with a 52-week high of $86.53 and a 52-week low of $31.01.

Can Indians buy Belite Bio- Adr shares?

Yes, Indians can invest in the Belite Bio- Adr (BLTE) from India.

With INDmoney, you can buy Belite Bio- Adr at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Belite Bio- Adr at zero transaction cost.

How can I buy Belite Bio- Adr shares from India?

It is very easy to buy Belite Bio- Adr from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Belite Bio- Adr (BLTE) be purchased?

Yes, you can buy fractional shares of Belite Bio- Adr with INDmoney app.

What are the documents required to start investing in Belite Bio- Adr stocks?

To start investing in Belite Bio- Adr, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Belite Bio- Adr Stock (BLTE)?

Today’s highest price of Belite Bio- Adr (BLTE) is $61.22.

Today’s lowest price of Belite Bio- Adr (BLTE) is $59.30.

What is today's market capitalisation of Belite Bio- Adr?

Today's market capitalisation of Belite Bio- Adr BLTE is 1.9B

What is the 52 Week High and Low Range of Belite Bio- Adr Stock (BLTE)?

  • 52 Week High

    $86.53

  • 52 Week Low

    $31.01

What are the historical returns of Belite Bio- Adr (BLTE)?

  • 1 Month Returns

    3%

  • 3 Months Returns

    22.54%

  • 1 Year Returns

    28.6%

  • 5 Years Returns

    308.19%

Who is the Chief Executive Officer (CEO) of Belite Bio- Adr ?

Dr. Yu-Hsin Lin M.B.A., Ph.D. is the current Chief Executive Officer (CEO) of Belite Bio- Adr.